Pharmacology
Sort by:
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Cardiovascular Safety and Benefits of PDE-5 Inhibition in Women with Female Sexual Dysfunction (FSD): Summary of Findings from Clinical Trials of PDE-5 Inhibition in Women
FEATURING
Irwin Goldstein
- 58 views
- July 18, 2023
- 1
AHA 2023 Insights
AHA 2023 Insights: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation - The ARTESIA Trial
FEATURING
Jeffrey Healey
- 2,672 views
- November 21, 2023
- 18
Houston Methodist DeBakey Heart and Vascular Center
Atrial Fibrillation: Past, Present and Future
FEATURING
Patrick Ellinor
- 2,700 views
- December 5, 2022
- 17
ACC 2023 Conference Coverage
ACC 2023: Can LAAC Be Considered a True Alternative to OAC?
FEATURING
Andrea Natale
- 3,348 views
- March 22, 2023
- 11
Houston Methodist DeBakey Heart and Vascular Center
Aspirin & Primary Prevention: What Do the Guidelines Say?
FEATURING
Martha Gulati
- 3,160 views
- January 25, 2022
- 13
CHEST 2022 Coverage
Perioperative Management of Antithrombotic Therapy
FEATURING
James Douketis
- 2,445 views
- October 25, 2022
- 17
Icahn School of Medicine at Mount Sinai
Peri-Operative Management of Anticoagulation
FEATURING
Andrew Dunn
- 819 views
- July 4, 2023
- 11
The North American Thrombosis Forum (NATF)
Case Presentation: What Anticoagulant a Hematologst Recommends to an Obese Patient
FEATURING
Tzu-Fei Wang
- 124 views
- May 16, 2023
- 2
Scripps Health
Management of Ventricular Tachycardia
FEATURING
Douglas Gibson
- 1,242 views
- June 13, 2023
- 13
Jefferson Health
Atrial Fibrillation - Current Guidelines and Future Directions
FEATURING
Richard Borge
- 2,349 views
- April 24, 2023
- 16
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias
Outpatient Management of Atrial Fibrillation
FEATURING
Nicholas Olson
- 1,111 views
- May 17, 2019
- 13
American College of Cardiology
MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High Bleeding Risk
- 196 views
- February 15, 2022
- 2
Cedars Sinai
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation - in Defense of Digoxin
FEATURING
John Mandrola
- 1,887 views
- February 8, 2022
- 15
AHA 2022 Conference Coverage
AHA 2022: Risk Stratification and Treatment of Ventricular Arrhythmias in Brugada Syndrome
FEATURING
Elizabeth Kaufman
- 595 views
- February 1, 2023
- 8
Nitesh Sood
Hybrid AFib Ablation: Persistent AFib Management in the Current Era
- 1,384 views
- July 20, 2022
- 12
Houston Methodist DeBakey Heart and Vascular Center
Left Ventricular Thrombosis: An Overview
FEATURING
Yehia Saleh
- 65 views
- June 14, 2023
- 1
UCLA Health
Anticoagulation in ECLS - To Bleed, or Not to Clot...
FEATURING
Andrew Young
- 66 views
- March 8, 2023
- 1
Cardiopulmonary Research Science and Technology Institute
Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation
FEATURING
Gregg Stone
- 2,383 views
- May 8, 2013
- 14
16th Annual Heart Failure Holiday Symposium
Cardiac Amyloidosis vs. Cardiorenal Syndrome: How to Diagnose and Treat the Patients?
FEATURING
Martha Grogan
- 619 views
- February 18, 2021
- 7
Penn Medicine Heart and Vascular Center
Lessons Learned from Using ILRs in Patients Undergoing Afib Ablation
FEATURING
David Frankel
- 136 views
- October 16, 2023
- 2
Canadian Collaborative Research Network
Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?
FEATURING
Marc Sabatine
- 137 views
- June 13, 2022
- 2